Skip to content

Endoscopic valuation study about the visibility of bleeding points by a novel image enhancement

Endoscopic valuation study about the visibility of bleeding points by a novel image enhancement - Endoscopic valuation study about the visibility of bleeding points by a novel image enhancement

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000046855
Enrollment
50
Registered
2022-02-28
Start date
2021-11-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal tumors (adenomas, cancer)

Interventions

None listed

Sponsors

Fujita Health University hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients provided safety endotherapy 2. Patient who will not refuse

Exclusion criteria

Exclusion criteria: Unsuitable conditions found by a doctor

Design outcomes

Primary

MeasureTime frame
We compare the visibility of a bleeding point between the original and the processed images using a 5-point Likert scale.

Secondary

MeasureTime frame
1, we calculate the average distance between a bleeding point and its surround in 3D color space and compare its color differences between the original and the processed images. 2, We compare the time until finding a bleeding point between the original and the processed images. 3, We evaluate whether the endoscopist's experience affects the subjective evaluation and the time until finding a bleeding point.

Countries

Japan

Contacts

Public ContactKohei Funasaka

Fujita Health University Department of Gastroenterology and Hepatology

k-funa@fujita-hu.ac.jp+81562932324

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026